Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

BMS-986020

DRUG

Placebo matching with BMS-986020

Trial Locations (72)

1

Local Institution, Lima

27

Local institution, Lima

33

Local institution, Lima

41

Local institution, Lima

2145

Local institution, Westmead

3199

Local institution, Frankston

4120

Local institution, Greenslopes

5000

Local Institution, Adelaide

6009

Local institution, Nedlands

10065

Weill Cornell Medical College, New York

11375

ISA Clinical Research, Forest Hills

14050

Local Institution, Mexico City

14080

Local Institution, Mexico City

14620

Highland Hospital, Rochester

15213

University of Pittsburgh Medical Center - Simmons Center for Interstitial Lung Disease, Pittsburgh

19140

Temple Lung Center, Philadelphia

21224

Johns Hopkins University, Baltimore

22042

Inova Fairfax Medical Campus, Falls Church

27710

Duke University Medical Center, Durham

28801

Asheville Pulmonary and Critical Care Associates, P.A., Asheville

32117

Advanced Pulmonary & Sleep Research Institute of Florida, Daytona Beach

33136

ILD Research Center, Miami

33331

Cleveland Clinic Florida- Weston Hospital, Weston

37232

Vanderbilt University, Nashville

40202

University of Louisville, Louisville

40513

University of Kentucky- Center for Clinical and Translational Science, Lexington

43221

The Ohio State University, Columbus

44100

Local Institution, Guadalajara

44195

Cleveland Clinic, Cleveland

45267

University of Cincinnati Pulmonary, Critical Care & Sleep Medicine, Cincinnati

53792

University of Wisconsin Hospital & Clinics, Madison

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic, Pulmonary Clinical Research Unit, Rochester

60637

University of Chicago, Chicago

63017

CardioPulmonary Research Center, Chesterfield

63110

Washington University School of Medicine, St Louis

64460

Local Institution, Monterrey

64710

Local Institution, Monterrey

66465

Local Institution, Monterrey

67028

Via Christi Clinic, Wichita

70112

Tulane University, New Orleans

75069

Metroplex Pulmonary and Sleep Center, McKinney

75708

University of Texas Health Science Center at Tyler, Tyler

78212

University of Texas Southwestern Medical Center - Dallas, Dallas

Alamo Clinical Research, San Antonio

80206

National Jewish Health, Denver

84108

University of Utah, Salt Lake City

85013

St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

90095

David Geffen School of Medicine at UCLA, Los Angeles

94143

University of California at San Francisco, San Francisco

97220

The Oregon Clinic, Portland

97239

Oregon Health Science University, Portland

3465584

Local Institution, Talca

35294-0006

University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care, Birmingham

94305-5236

Stanford University Medical Center, Stanford

06511

Yale University School of Medicine, Section of Pulmonary & Critical Care, New Haven

32610-0225

University of Florida, Gainesville

02120

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

48109-5360

University of Michigan Health System, Ann Arbor

03756

Dartmouth-Hitchcock Medical Center, Lebanon

07901

Pulmonary & Allergy Associates, PA, Summit

05444

Vermont Lung Center, Colchester

Unknown

Local institution, Viña del Mar

Local institution, Quillota

Local institution, Santiago

Hospital Pablo Tobon Uribe, Medellín

Fundacion Neumologica Colombiana, Bogota

Hospital Universitario San Ignacio, Bogota

Local Institution, Bogota

01

Local institution, Lima

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY